Novartis Investigative Site

Istanbul, Sariyer 34457

1 studies enrolling now · 3 studies all time

What they study most

Early Breast Cancer, IgA Nephropathy, Primary IgA Nephropathy

Studies at this site

• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy — Running, not enrolling
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed